ARDC vs TSBK

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 1/9, indicating severe operational and balance sheet deterioration. Despite a current price of $13.50 and a seemingly low P/E of 10.80, the lack of profitability metrics (0% margins across the board), absence of key financial ratios, and a dangerously high 110.8% payout ratio undermine sustainability. The stock trades well above its growth-approximated intrinsic value of $8.75, with no Altman Z-Score to counterbalance bankruptcy risk. Technical trend is deeply bearish (0/100), and insider sentiment is weak, further validating caution.

TSBK presents a dichotomy between strong fundamental value and bearish sentiment. The company maintains a stable health profile with a Piotroski F-Score of 4/9 and trades at a significant discount to both its Graham Number ($54.32) and Intrinsic Value ($113.58). While earnings growth is robust at 20.9% YoY and the P/E ratio is attractive at 10.72, these positives are heavily offset by a very bearish technical trend (10/100) and aggressive insider selling by the CFO and President. The stock is fundamentally undervalued but currently lacks a positive catalyst.